Archive

Duloxetine shows efficacy for pain associated with breast cancer treatment

By Bruce Sylvester Duloxetine (Cymbalta ®), a widely-used treatment for depression and anxiety, appears to reduce joint pain in postmenopausal women being treated for early stage breast cancer,… read more.

EMA Highlights: Spain and Italy pushing to host EU drug watchdog

by Gary Finnegan: Within hours of the UK’s vote to leave the European Union, at least half a dozen countries began to call for the European Medicines Agency… read more.

Acetaminophen does not worsen asthma in young children

by Bruce Sylvester: Treatment of pain and fever with acetaminophen (Tylenol, etc.) does not exacerbate asthma in young children, researchers reported on August 18 NEJM/New England Journal of Medicine.

When the 100-year-old man can no longer climb out of the window

100-year-old persons are affected by substantial numbers of illnesses, and the frequency of untreated pain in this cohort is alarming. This is the result reported by Daniela Jopp… read more.

Less painkilling medication with breast-cancer surgery after opiate-free anesthesia

New research presented at Euroanaesthesia 2016 (London 27-30 May) shows that patients undergoing breast cancer surgery need less painkilling medication post-surgery if they have anaesthesia that is free… read more.

Benefits of careful monitoring of chronic pain patients

Within the past 10 years, the prescription of opioids for the treatment of chronic pain has increased and the abuse of opioid medications leading to addiction has been… read more.

Link between back pain and depression

Genetic factors help to explain the commonly found association between low back pain and depression, suggests a large study of twins in the March issue of PAIN®.

Rise in post-surgical opioid prescriping raises concerns, elicits new US guideline

by Bruce Sylvester: Patients who have undergone common surgeries are receiving opioid painkillers at an increasing rate, researchers reported on March 18, 2016 in JAMA/Journal of the American… read more.

EHA 2016: Consolidation and maintenance therapy for multiple myeloma: is it the new standard? Professor Paul Richardson (Harvard Medical School, Boston, USA) and Professor Maria-Victoria Mateos (Salamanca, Spain) discuss the meta-analysis of OS in myeloma with maintenance therapy presented at ASCO and EHA this year, along with strategies for continuous therapies

Consolidation and maintenance therapy for multiple myeloma: is it the new standard?   Professor Antonio Palumbo (University of Turin, Italy) and Professor Paul Richardson (Harvard Medical School, Boston,… read more.

EHA 2016: A new multiple myeloma classification system that correlates to disease stage and prognosis

Hans Erik Johnsen, Aalborg University Hospital, Denmark. by Maria Dalby:  The gene expression profiles of myeloma plasma cells in the normal bone marrow can be used for defining… read more.

EHA 2016: Smouldering Myeloma. Professor Maria-Victoria Mateos (Salamanca, Spain) discusses recent changes to the management of smouldering myeloma, her recommended work-up for these patients and the role of early treatment in this cohort.

World Health Matters: United State: ‘Green light’ signals relief for migraine patients

by Gary Finnegan: Exposing migraine sufferers to a narrow band of green light significantly reduces light sensitivity and can reduce headache severity, according to a new study led… read more.